Focus Feature: New tool helps predict outcomes for COVID-19

A risk assessment tool developed by Kaiser Permanente researchers and physicians helps ensure patients get the right care, when they need it, by accurately predicting the probability that patients with COVID-19 symptoms will experience severe disease or even death.

R&E News and Features

  • Progression of children’s myopia may be influenced by race and ethnicity

    Asian American children are at a much higher risk of a progression of myopia, commonly known as nearsightedness, new research shows.

  • People on dialysis have higher risk from COVID-19

    Patients on dialysis have 18 times higher risk of hospitalization and death from COVID-19 than people who do not have end-stage kidney disease, new research shows.

  • Seeking early detection for pancreatic cancer

    In a newly released video, Dr.  Bechien Wu, MD,  MPH, discusses what he and a team of physicians, biostatisticians, data scientists, epidemiologists, and radiologists are doing to improve early detection of pancreatic cancer.

  • Kaiser Permanente San Diego enrolling patients in monoclonal antibody trial

    In November, emergency departments at the Kaiser Permanente San Diego and Zion medical centers began enrolling patients in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies trial.

In the News

Five questions...

for Dr. Chunyuan Qiu

Chunyuan Qiu, MD, MS, answers questions about his life and work as a clinician investigator for the Department of Research & Evaluation and the chief of the Department of Anesthesiology at Kaiser Permanente Baldwin Park Medical Center.